Browsing Wolfson Institute of Preventive Medicine by Subject "ErbB Receptors"

Now showing items 1-2 of 2

    • Cost-effectiveness of osimertinib in the treatment of advanced EGFR-mutated non-small cell lung cancer: a systematic review. 

      Nargesi, S; Dolatshahi, Z; Rezapour, A; Alipour, V; Souresrafil, A; Farabi, H; Javadmoosavi, SA; Safakhah, M; Moradi, N (Taylor & Francis, 2021-12-12)
      BACKGROUND: The most common type of lung cancer is advanced and mutant non-small cell lung cancer (NSCLC). Although targeted tyrosine kinase inhibitors (TKIs) have reconstructed the care of these patients, the resistance ...

    • Lung adenocarcinoma promotion by air pollutants. 

      Hill, W; Lim, EL; Weeden, CE; Lee, C; Augustine, M; Chen, K; Kuan, F-C; Marongiu, F; Evans, EJ; Moore, DA (Nature, 2023-04-05)
      A complete understanding of how exposure to environmental substances promotes cancer formation is lacking. More than 70 years ago, tumorigenesis was proposed to occur in a two-step process: an initiating step that induces ...